Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Prosthetics
eksobionics.com

See what CB Insights has to offer

Founded Year

2005

Stage

IPO | IPO

Total Raised

$25.07M

Date of IPO

5/22/2019

Market Cap

0.07B

Stock Price

4.95

About Ekso Bionics

Ekso Bionics EKSO (NASDAQ) is a designer and maker of wearable robots, or bionic suits, that physically augment humans. The company is committed to applying the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable.

Ekso Bionics Headquarter Location

1414 Harbour Way South Suite 1201

Berkeley, California, 94084,

United States

415-533-8062

Latest Ekso Bionics News

Arena Raises USD 5.2M in Funding

Jul 8, 2021

Arena Innovation Corp., a San Francisco, CA-based connected fitness company, secured USD 5.2M in seed financing. Backers included Courtside Ventures, Powerhouse Capital, and Wellness Holding, the investment office of the founders of Technogym, as well as angel investors Equinox Group co-founder Lavinia Errico, Anthony and Joe Vennare of Fitt Insider, New York Jets wide receiver Braxton Berrios, and Russ Angold, co-founder and former CTO of Ekso Bionics.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ekso Bionics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ekso Bionics is included in 4 Expert Collections, including Construction Tech.

C

Construction Tech

576 items

Companies using technology to improve processes in the construction industry.

R

Robotics

1,636 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.

I

Internet of Things ( IoT )

3,149 items

M

Medical Devices

8,341 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Ekso Bionics Patents

Ekso Bionics has filed 46 patents.

The 3 most popular patent topics include:

  • Robotic exoskeletons
  • Animal anatomy
  • Assistive technology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/14/2017

6/29/2021

Desks, Mechanics, Metalworking cutting tools, Cutting tools, Metalworking

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/14/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/29/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Desks, Mechanics, Metalworking cutting tools, Cutting tools, Metalworking

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Ekso Bionics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ekso Bionics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.